Header Logo

Connection

GUILLERMO GARCIA-MANERO to Myeloid Cell Leukemia Sequence 1 Protein

Back to Details
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Myeloid Cell Leukemia Sequence 1 Protein.
GUILLERMO GARCIA-MANERO
Connection Strength
0.052
Myeloid Cell Leukemia Sequence 1 Protein
  1. A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood Cancer J. 2023 06 29; 13(1):101.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.